DocGo (NASDAQ:DCGO - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.08), Zacks reports. DocGo had a net margin of 4.35% and a return on equity of 8.90%. DocGo updated its FY 2025 guidance to EPS.
DocGo Price Performance
Shares of DCGO stock traded down $0.92 during mid-day trading on Friday, hitting $1.41. The stock had a trading volume of 9,518,179 shares, compared to its average volume of 763,955. DocGo has a 12-month low of $1.39 and a 12-month high of $5.68. The firm's 50-day moving average is $2.52 and its two-hundred day moving average is $3.68. The firm has a market capitalization of $143.80 million, a P/E ratio of 5.04, a price-to-earnings-growth ratio of 14.16 and a beta of 1.14.
Analysts Set New Price Targets
A number of research analysts have recently commented on DCGO shares. BTIG Research cut DocGo from a "buy" rating to a "neutral" rating in a research note on Friday. Deutsche Bank Aktiengesellschaft downgraded DocGo from a "buy" rating to a "hold" rating and cut their price objective for the company from $5.00 to $2.85 in a research report on Friday, February 28th. Stifel Nicolaus decreased their target price on DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a research report on Friday, February 28th. Finally, Needham & Company LLC reduced their price target on shares of DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a research note on Friday. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $4.09.
View Our Latest Report on DocGo
About DocGo
(
Get Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.